Package 45802-974-26

Brand: cetirizine hydrochloride

Generic: cetirizine hydrochloride
NDC Package

Package Facts

Identity

Package NDC 45802-974-26
Digits Only 4580297426
Product NDC 45802-974
Product ID 45802-974_71411b7e-4fb8-4c33-b260-287128711d0a
Description

1 BOTTLE in 1 CARTON (45802-974-26) / 118 mL in 1 BOTTLE

Marketing

Marketing Status
Marketed Since 2008-04-15
Brand cetirizine hydrochloride
Generic cetirizine hydrochloride
Sample Package No

Linked Drug Pages (1)

cetirizine hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "71411b7e-4fb8-4c33-b260-287128711d0a", "openfda": {"unii": ["64O047KTOA"], "rxcui": ["1014673"], "spl_set_id": ["c2cf555d-986c-4e89-ac4f-938e92c418e2"], "manufacturer_name": ["Padagis Israel Pharmaceuticals Ltd"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (45802-974-26)  / 118 mL in 1 BOTTLE", "package_ndc": "45802-974-26", "marketing_start_date": "20080415"}], "brand_name": "cetirizine hydrochloride", "product_id": "45802-974_71411b7e-4fb8-4c33-b260-287128711d0a", "dosage_form": "SOLUTION", "pharm_class": ["Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]"], "product_ndc": "45802-974", "generic_name": "cetirizine hydrochloride", "labeler_name": "Padagis Israel Pharmaceuticals Ltd", "product_type": "HUMAN OTC DRUG", "brand_name_base": "cetirizine hydrochloride", "active_ingredients": [{"name": "CETIRIZINE HYDROCHLORIDE", "strength": "5 mg/5mL"}], "application_number": "ANDA090254", "marketing_category": "ANDA", "marketing_start_date": "20080415", "listing_expiration_date": "20261231"}